Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.9575
Delayed Data
As of Sep 28
 +0.0501 / +5.52%
Today’s Change
0.26
Today|||52-Week Range
2.40
-28.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash9.1M32.9M5.5M7.2M
 
 
 
 
 
Short Term Investment Cash-19.5M23.8M-27.5M1.7M
 
 
 
 
 
Cash & Short Term Investments9.1M32.9M5.5M7.2M
 
 
 
 
 
 
ReceivablesReceivables17.6K1.2M816.5K3.7M
 
 
 
 
 
 
InventoriesInventories297.5K2.2M932.4K652.9K
 
 
 
 
 
 
Current AssetsOther Current Assets1.2M1.0M1.4M1.1M
 
 
 
 
 
Current Assets10.6M37.3M8.6M12.6M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.0M3.6M4.1M3.9M
 
 
 
 
 
Depreciation-1.1M-1.5M-1.6M-1.9M
 
 
 
 
 
Intangible Assets92.5K136.9K180.8K186.2K
 
 
 
 
 
Other Assets420.4K860.0K569.8K459.7K
 
 
 
 
 
Total Assets12.0M40.3M11.9M15.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.4M2.4M1.5M1.8M
 
 
 
 
 
Short Term Debt2.8M4.1M4.4M333.3K
 
 
 
 
 
Accrued Expenses1.3M3.6M2.3M2.1M
 
 
 
 
 
Other Current Liabilities1.3M3.6M2.3M3.2M
 
 
 
 
 
Other Liabilities6.2M11.3M9.1M6.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt6.9M23.6M29.5M60.7M
 
 
 
 
 
Other Liabilities257.1K9.5M3.1M1.7M
 
 
 
 
 
Total Liabilities13.4M44.3M41.7M68.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.00-855.00
 
 
Preferred Stock7.008.004.000.00
 
 
 
 
Common Equity-1.4M-4.0M-29.8M-54.3M
 
 
 
 
 
Total Shareholder Equity-1.4M-4.0M-29.8M-54.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding113.0M135.9M150.2M155.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.